Skip to main content

Published locations for JAK inhibitors for RA: Is VTE risk overblown?

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. JAK inhibitors for RA: Is VTE risk overblown?

User login

  • Reset your password
  • /content/jak-inhibitors-ra-vte-risk-overblown
  • /hematologynews/article/158782/rheumatoid-arthritis/jak-inhibitors-ra-vte-risk-overblown
  • /internalmedicinenews/article/158782/rheumatoid-arthritis/jak-inhibitors-ra-vte-risk-overblown
  • /rheumatologynews/article/158782/rheumatoid-arthritis/jak-inhibitors-ra-vte-risk-overblown
  • /vascularspecialistonline/article/158782/rheumatoid-arthritis/jak-inhibitors-ra-vte-risk-overblown
  • /anticoagulationhub/article/158782/rheumatoid-arthritis/jak-inhibitors-ra-vte-risk-overblown
  • /hematology-oncology/article/158782/rheumatoid-arthritis/jak-inhibitors-ra-vte-risk-overblown
  • /ecardiologynews/article/158782/rheumatoid-arthritis/jak-inhibitors-ra-vte-risk-overblown
  • /cardiology/article/158782/rheumatoid-arthritis/jak-inhibitors-ra-vte-risk-overblown
  • /rheumatology/article/158782/rheumatoid-arthritis/jak-inhibitors-ra-vte-risk-overblown
  • /internalmedicine/article/158782/rheumatoid-arthritis/jak-inhibitors-ra-vte-risk-overblown